Article Correctness Is Author's Responsibility: Exploring new option to manage pediatric myopia

(State University of New York College of Optometry) SUNY College of Optometry will take part in a multi-center US clinical trial sponsored by Eyenovia, Inc. to evaluate the safety and effectiveness of an investigational drug, MicroPine, to help slow myopic progression in children 3 to12 years old. MicroPine is an atropine eye solution formulated for administration as a gentle mist using the company's patented microdose dispenser.